Skip to main content

Compare Stocks

Date Range: 

 Evolent HealthFranklin CoveyJupaiPHI GroupRainmaker Systems
SymbolNYSE:EVHNYSE:FCNYSE:JPOTCMKTS:PHILOTCMKTS:VCTL
Price Information
Current Price$19.98$30.38$1.97$0.00$0.01
52 Week RangeBuyBuyN/AN/AN/A
MarketRank™
Overall Score1.41.40.70.50.5
Analysis Score2.41.40.00.00.0
Community Score3.12.72.72.52.6
Dividend Score0.00.00.00.00.0
Ownership Score1.70.80.00.00.0
Earnings & Valuation Score0.01.90.60.00.0
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/AN/A
Consensus Price Target$18.20$32.00N/AN/AN/A
% Upside from Price Target-8.91% downside5.33% upsideN/AN/AN/A
Trade Information
Market Cap$1.72 billion$429.76 million$66.42 million$64.54 millionN/A
Beta2.41.641.522.270.07
Average Volume566,17073,656178,253635,247,68849,751
Sales & Book Value
Annual Revenue$846.38 million$198.46 million$112.89 million$1.67 millionN/A
Price / Sales2.032.170.5938.65N/A
Cashflow$2.77 per share$1.54 per shareN/AN/AN/A
Price / Cash7.2119.70N/AN/AN/A
Book Value$10.98 per share$4.19 per share$5.12 per shareN/AN/A
Price / Book1.827.250.38N/A
Profitability
Net Income$-301,970,000.00$-9,440,000.00$-23,660,000.00$-2,020,000.00N/A
EPS($0.91)$0.14N/AN/AN/A
Trailing P/E RatioN/AN/AN/A0.000.00
Forward P/E RatioN/A66.04
P/E GrowthN/A50.71N/AN/AN/A
Net Margins-52.35%-5.20%-15.03%N/AN/A
Return on Equity (ROE)-4.40%2.45%-5.68%N/AN/A
Return on Assets (ROA)-2.41%0.76%-4.42%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.44%0.46%N/AN/AN/A
Current Ratio1.50%0.99%2.70%N/AN/A
Quick Ratio1.50%0.96%2.70%N/AN/A
Ownership Information
Institutional Ownership Percentage93.15%57.62%10.57%N/AN/A
Insider Ownership Percentage5.00%14.00%N/A31.96%7.60%
Miscellaneous
Employees2,900940580N/A150
Shares Outstanding86.09 million14.15 million33.71 million24.82 billionN/A
Next Earnings Date8/3/2021 (Estimated)7/8/2021 (Estimated)5/27/2021 (Estimated)N/AN/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
SourceHeadline
Should You Take Comfort From Insider Transactions At F5 Networks, Inc. (NASDAQ:FFIV)?Should You Take Comfort From Insider Transactions At F5 Networks, Inc. (NASDAQ:FFIV)?
finance.yahoo.com - January 13 at 8:58 AM
F5 Networks Relative Strength Improves After AcquisitionF5 Networks Relative Strength Improves After Acquisition
finance.yahoo.com - January 11 at 1:17 PM
F5 Networks (NASDAQ:FFIV) Seems To Use Debt Quite SensiblyF5 Networks (NASDAQ:FFIV) Seems To Use Debt Quite Sensibly
finance.yahoo.com - December 18 at 9:03 AM
F5 to Participate in Upcoming Financial ConferencesF5 to Participate in Upcoming Financial Conferences
finance.yahoo.com - December 1 at 5:01 PM
Application Security and Delivery Leader F5 Joins 5G Open Innovation Lab as a Corporate Partner to Help Ecosystem Members Accelerate 5G as a Platform for Cloud, Telco ApplicationsApplication Security and Delivery Leader F5 Joins 5G Open Innovation Lab as a Corporate Partner to Help Ecosystem Members Accelerate 5G as a Platform for Cloud, Telco Applications
finance.yahoo.com - November 10 at 12:08 PM
F5 Introduces Solutions for Cloud-Native 5G Infrastructure Enabling Service Providers to Accelerate Delivery of New Digital ExperiencesF5 Introduces Solutions for Cloud-Native 5G Infrastructure Enabling Service Providers to Accelerate Delivery of New Digital Experiences
finance.yahoo.com - November 10 at 12:08 PM
F5 Shares Jump on Report of Elliott Stake. Company Sets $1 Billion Buyback Plan.F5 Shares Jump on Report of Elliott Stake. Company Sets $1 Billion Buyback Plan.
finance.yahoo.com - November 9 at 3:45 PM
F5 Delivers 5% Revenue Growth in Fiscal Year 2020 on Building Software MomentumF5 Delivers 5% Revenue Growth in Fiscal Year 2020 on Building Software Momentum
finance.yahoo.com - October 26 at 6:56 PM
Did F5 Networks' (NASDAQ:FFIV) Share Price Deserve to Gain 11%?Did F5 Networks' (NASDAQ:FFIV) Share Price Deserve to Gain 11%?
finance.yahoo.com - October 16 at 5:32 PM
Is There Now An Opportunity In F5 Networks, Inc. (NASDAQ:FFIV)?Is There Now An Opportunity In F5 Networks, Inc. (NASDAQ:FFIV)?
finance.yahoo.com - August 27 at 2:14 PM
Insider Buying: Thomas Fountain Just Spent US$1.1m On F5 Networks, Inc. (NASDAQ:FFIV) SharesInsider Buying: Thomas Fountain Just Spent US$1.1m On F5 Networks, Inc. (NASDAQ:FFIV) Shares
finance.yahoo.com - August 5 at 8:37 AM
F5 Networks Beats 3Q Estimates, Stock Drops 4% in After-HoursF5 Networks Beats 3Q Estimates, Stock Drops 4% in After-Hours
finance.yahoo.com - July 28 at 8:38 AM
F5 Delivers 4% Revenue Growth on Continued Strong Software Demand in Third Quarter Fiscal Year 2020F5 Delivers 4% Revenue Growth on Continued Strong Software Demand in Third Quarter Fiscal Year 2020
finance.yahoo.com - July 27 at 6:14 PM
F5 Networks Stock Trades Higher as Profits Top Street EstimatesF5 Networks Stock Trades Higher as Profits Top Street Estimates
finance.yahoo.com - July 27 at 6:14 PM
Are Robust Financials Driving The Recent Rally In F5 Networks, Inc.'s (NASDAQ:FFIV) Stock?Are Robust Financials Driving The Recent Rally In F5 Networks, Inc.'s (NASDAQ:FFIV) Stock?
finance.yahoo.com - July 20 at 7:08 PM
3 Software Stocks Gaining Momentum3 Software Stocks Gaining Momentum
finance.yahoo.com - July 10 at 12:56 PM
F5 Fortifies Partnership with Rakuten Mobile to Provide Advanced Application Security Services for the Rakuten Communications PlatformF5 Fortifies Partnership with Rakuten Mobile to Provide Advanced Application Security Services for the Rakuten Communications Platform
finance.yahoo.com - June 29 at 10:28 PM
Hedge Funds Aren’t Done Buying F5 Networks, Inc. (FFIV)Hedge Funds Aren’t Done Buying F5 Networks, Inc. (FFIV)
finance.yahoo.com - June 4 at 11:17 PM
F5 Names Tom Fountain as Head of Global Services and StrategyF5 Names Tom Fountain as Head of Global Services and Strategy
finance.yahoo.com - May 21 at 7:14 PM
Rainmaker Systems IncRainmaker Systems Inc
markets.ft.com - October 2 at 9:24 PM
DateCompanyBrokerageAction
5/6/2021Evolent HealthPiper SandlerBoost Price Target
4/29/2021Evolent HealthJPMorgan Chase & Co.Initiated Coverage
3/8/2021Evolent HealthCanaccord GenuityBoost Price Target
2/26/2021Evolent HealthCowenBoost Price Target
2/26/2021Evolent HealthBTIG ResearchBoost Price Target
8/5/2020Evolent HealthTruist FinancialBoost Price Target
8/5/2020Evolent HealthCantor FitzgeraldBoost Price Target
7/20/2020Evolent HealthRobert W. BairdBoost Price Target
7/20/2020Evolent HealthSunTrust BanksBoost Price Target
6/5/2020Evolent HealthThe Goldman Sachs GroupDowngrade
4/5/2021Franklin CoveyRoth CapitalBoost Price Target
4/5/2021Franklin CoveyBarrington ResearchBoost Price Target
11/6/2020Franklin CoveyWilliam BlairReiterated Rating
7/10/2020Franklin CoveyB. RileyLower Price Target
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.